Skip to content

Comstock Inc. LODE Bioleum — Goodwill

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Goodwill
$462M-42.8%
Mesa Laboratories logo
MLABBiopharmaceutical Development — Goodwill
$49.67M+3.0%
Becton, Dickinson and Company logo
BDXBioPharma Systems — Goodwill
$96M
WAT
WATBiosciences — Goodwill
$3.8B
Danaher logo
DHRLife Sciences — Goodwill
$12.81B+2.4%
Thermo Fisher Scientific logo
TMOLaboratory Products and Biopharma Services — Goodwill
$24.23B+1.9%

Other financials

Income statement

See full
Revenue$313.5K-60.1%
Gross profit-$286.4K-184%
Operating income-$8.9M-27.1%
Net income-$9.4M-3.2%
EPS (diluted)-$3.01-450%

Balance sheet

See full
Cash & equivalents$53.0M+212%
Total debt$257.3K-98.8%
Total equity$156.4M
Total assets$218.1M+28.6%

Cash flow

See full
Operating cash flow-$5.8M-17.3%
CapEx--100%
Free cash flow-$3.5M+2.7%

Valuation

See full
Market cap$302.13M+177%
Enterprise value$249.42M+118%
P/S279.4×+247×

Profitability

See full
Gross margin-116.4%-177pp
Operating margin-3,703.7%-7,510pp
Net margin-4,010%-13,152pp
FCF margin-462.3%-171pp

Returns & leverage

See full
Return on equity-51.5%-12.9pp
Debt / equity
Current ratio4.5×+2.1×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Comstock Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Comstock Inc.'s bioleum — goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Comstock Inc.'s bioleum — goodwill?
Comstock Inc. (LODE) reported bioleum — goodwill of $1.51M in Q1 2026.
What does bioleum — goodwill mean?
The excess purchase price paid for acquisitions within the Bioleum segment over the fair value of the identifiable net assets acquired. It represents the premium paid for intangible synergies, brand reputation, and future growth potential specific to this business unit.